CANL 0.01 CannLabs, Inc.
| Range: | 1.0E-6-0.009 | Vol Avg: | 0 | Last Div: | 0 | Changes: | -0.01 |
| Beta: | 271.96 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Fri Jun 13 2014 | Empoloyees: | 37 | ||
| CUSIP: | 13767T102 | CIK: | ISIN: | US13767T1025 | Country: | US | |
| CEO: | Mr. Mark C. Mirken | Website: | https://www.cannlabs.net | ||||
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow